A Randomized, Double-Blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma.

Trial Profile

A Randomized, Double-Blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Feb 2014

At a glance

  • Drugs R 1671 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 17 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jul 2009 Actual patient number (43) added as reported by ClinicalTrials.gov.
    • 15 May 2009 Planned end date changed from 1 Aug 2009 to 1 Nov 2009 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top